[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported two sales of common stock under a Rule 10b5-1 plan. The filings show a sale of 1,000 shares on 09/05/2025 at $38.00 and a sale of 1,000 shares on 09/08/2025 at $38.51, reducing his beneficially owned common stock to 41,754 shares. The report also lists outstanding non-qualified stock options exercisable into common stock: 14,205 shares at a $16.91 strike, 13,481 at $24.35, 8,746 at $26.18, 11,547 at $27.59 and 13,218 at $33.36, each held directly. Several option grants have scheduled vesting dates and installment vesting schedules as described by the reporting person.

Positive

• Transactions executed under a Rule 10b5-1 plan, indicating pre-established trading instructions and compliance with insider trading protocols
• Detailed option and vesting schedules disclosed, providing transparency about future potential dilution and executive alignment with equity

Negative

• Reduction in direct common stock holdings from 42,754 to 41,754 shares following the reported sales

Insights

Financial Analyst

TL;DR: Routine insider sales under a 10b5-1 plan; no new equity issuance or debt changes reported.

The Form 4 discloses two small open-market sales by the CFO executed pursuant to a pre-established Rule 10b5-1 trading plan, which suggests these transactions follow a predetermined schedule rather than opportunistic timing. The filing confirms continued equity exposure via substantial outstanding options across multiple strike prices and staggered vesting schedules. There is no indication in the filing of additional corporate actions or material changes to capital structure.

Corporate Governance Expert

TL;DR: Disclosure is compliant and shows typical officer liquidity within a structured trading plan.

The report includes required details: transaction dates, amounts, prices, ownership after sale, and explanatory vesting terms for options. Use of a Rule 10b5-1 plan is explicitly noted, which supports an affirmative defense to insider trading claims so long as plan conditions were met. The attestation by an attorney-in-fact is present. No governance irregularities or departures are disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAKER COREY

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		S(1)		1,000	D	$38	42,754	D
Common Stock	09/08/2025		S(1)		1,000	D	$38.51	41,754	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$16.91							(2)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$24.35							(3)	05/10/2033	Common Stock	13,481		13,481	D
Non-Qualified Stock Option (right to buy)	$26.18							(4)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$27.59							(3)	08/07/2033	Common Stock	11,547		11,547	D
Non-Qualified Stock Option (right to buy)	$33.36							(5)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option vests in four equal annual installments beginning on March 10, 2024.

3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.

4. The stock option vests in four equal annual installments beginning on March 4, 2025.

5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Corey Baker	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What trades did COCO CFO Corey Baker report on Form 4?

The Form 4 reports sales of 1,000 shares on 09/05/2025 at $38.00 and 1,000 shares on 09/08/2025 at $38.51.

Were the sales by Corey Baker part of a 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

How many shares does Corey Baker beneficially own after these transactions?

Following the reported transactions, the filing shows Corey Baker beneficially owns 41,754 shares of common stock.

What stock options does Corey Baker hold according to the Form 4?

The Form 4 lists non-qualified stock options exercisable into 14,205; 13,481; 8,746; 11,547; and 13,218 common shares at strikes of $16.91, $24.35, $26.18, $27.59, and $33.36, respectively.

Are there vesting schedules disclosed for the options?

Yes. The filing discloses various vesting schedules including four-year installment vesting and specific milestone vesting dates for certain grants.